Crosstalk Between Insulin and Dopamine Signaling: A Basis for the Metabolic Effects of Antipsychotic Drugs

Publication date: Available online 29 July 2016 Source:Journal of Chemical Neuroanatomy Author(s): Abigail I. Nash In the setting of rising rates of obesity and metabolic syndrome, characterized in part by hyperinsulinemia, it is increasingly important to understand the mechanisms that contribute to insulin dysregulation. The higher risk for metabolic syndrome imparted by antipsychotic medication use highlights one such mechanism. Though there is great variation in the number and types of signaling pathways targeted by these medications, the one common mechanism of action is through dopamine. Dopamine’s effects on insulin signaling begin at the level of insulin secretion from the pancreas and continue through the central nervous system. In a reciprocal fashion, insulin also affects dopamine signaling, with specific effects on dopamine reuptake from the synapse. This review probes the dopamine-insulin connection to provide a comprehensive examination of how antipsychotics may contribute towards insulin resistance.
Source: Journal of Chemical Neuroanatomy - Category: Neuroscience Source Type: research